Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
135 studies found for:    daniel lee | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Cochlear Implantation for Treatment of Single-sided Deafness
Conditions: Total Unilateral Deafness;   Unilateral Partial Deafness
Intervention: Device: Med-el MAESTRO Cochlear Implant with Flex 28 electrode array
2 Recruiting Short-course Methenamine Hippurate for Prevention of Post-operative UTI
Conditions: Urinary Tract Infections;   Catheter-Related Infections
Interventions: Drug: methenamine hippurate;   Drug: Ciprofloxacin
3 Recruiting Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects
Condition: Bilateral Hearing Loss for Causes Other Than Tumors
Intervention: Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
4 Recruiting Absorb IV Randomized Controlled Trial
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
5 Recruiting Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects
Condition: Bilateral Hearing Loss for Causes Other Than Tumors
Intervention: Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
6 Recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
7 Recruiting ExploR™ Modular Radial Head Data Collection
Condition: Elbow Fracture
Intervention: Device: Explore Modular Radial Head
8 Recruiting Vitamin E Supplementation in Burn Patients
Condition: Burn Injury
Intervention: Drug: dl-alpha-tocopheryl acetate
9 Recruiting S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: R-CHOP regimen;   Other: laboratory biomarker analysis;   Radiation: fludeoxyglucose F 18;   Radiation: selective external radiation therapy;   Radiation: yttrium Y 90 ibritumomab tiuxetan
10 Recruiting Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study
Conditions: Depression;   Pregnancy
Interventions: Device: Active tDCS;   Device: Sham tDCS
11 Recruiting Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms
Condition: Breast Implant
Intervention:
12 Recruiting A Multi-Center Trial to Study Acute Liver Failure in Adults
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Acute Liver Injury
Intervention:
13 Recruiting Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure
Conditions: Acute Liver Failure;   Acute Liver Injury
Intervention: Drug: Ornithine phenylacetate
14 Recruiting A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients
Condition: Chronic Myeloid Leukemia
Interventions: Drug: 600mg/day of Imatinib;   Drug: 400mg/day of Imatinib
15 Recruiting A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
Condition: Osteoarthritis, Degenerative
Interventions: Device: Pulsed Low Intensity Ultrasound;   Device: Sham Comparator
16 Recruiting 13C-Methacetin Breath Test for the Prediction of Outcome in ALF
Condition: Acute Liver Failure
Intervention: Drug: 13C-methacetin
17 Recruiting Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Prostatectomy;   Other: Quality of Life Questionnaires
18 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
19 Recruiting Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma;   Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Methotrexate;   Drug: Gemcitabine;   Other: Lung Cancer Symptom Scale for Mesothelioma Questionnaire
20 Recruiting Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
Condition: Multiple Myeloma
Interventions: Biological: Survivin Vaccine;   Procedure: Autologous Hematopoietic Cell Transplantation;   Biological: Prevnar 13;   Drug: Granulocyte-colony Stimulating Factor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.